Open access · CC-BY
via OpenAlex
DNA Methylation Age Acceleration Is Not Associated with Age of Onset in Parkinson's Disease
Johannes Jernqvist Gaare, Kim Brügger, Gonzalo S. Nido, Charalampos Tzoulis
Movement Disorders · 2023 · ▲ 12 citations
Abstract
BACKGROUND: Epigenetic clocks using DNA methylation (DNAm) to estimate biological age have become popular tools in the study of neurodegenerative diseases. Notably, several recent reports have shown a strikingly similar inverse relationship between accelerated biological aging, as measured by DNAm, and the age of onset of several neurodegenerative disorders, including Parkinson's disease (PD). Common to all of these studies is that they were performed without control subjects and using the exact same measure of accelerated aging: DNAm age minus chronological age. OBJECTIVE: We aimed to assess the validity of these findings in PD, using the same dataset as in the original study, blood DNAm data from the Parkinson's Progression Markers Initiative cohort, but also including control samples in the analyses. METHODS: We replicated the analyses and findings of the previous study and then reanalyzed the dataset incorporating control samples to account for underlying age-related biases. RESULTS: Our reanalysis shows that there is no correlation between age of onset and DNAm age acceleration. Conversely, there is a pattern of overestimating DNAm age in younger and underestimating DNAm age in older individuals in the dataset that entirely explains the previously reported association. CONCLUSIONS: Our findings refute the previously reported inverse relationship between DNAm age acceleration and age of onset in PD. We show that these findings are fully accounted for by an expected over/underestimation of DNAm age in younger/older individuals. Furthermore, this effect is likely to be responsible for nearly identical findings reported in other neurodegenerative diseases. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/mds.29574
- Canonical
- link ↗
- Fetched
- 2026-10-18 MST
Cite this
APA
Gaare, J.J., Brügger, K., Nido, G.S., & Tzoulis, C. (2023). DNA Methylation Age Acceleration Is Not Associated with Age of Onset in Parkinson's Disease. <em>Movement Disorders</em>. https://doi.org/10.1002/mds.29574
Vancouver
Gaare JJ, Brügger K, Nido GS, Tzoulis C. DNA Methylation Age Acceleration Is Not Associated with Age of Onset in Parkinson's Disease. Movement Disorders. 2023. doi:10.1002/mds.29574.
BibTeX
@article{johannes2023DNAMet,
title = {DNA Methylation Age Acceleration Is Not Associated with Age of Onset in Parkinson's Disease},
author = {Johannes Jernqvist Gaare and Kim Brügger and Gonzalo S. Nido and Charalampos Tzoulis},
journal = {Movement Disorders},
year = {2023},
doi = {10.1002/mds.29574},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging 2026
Open access · CC-BY
Association of epigenetic age acceleration with MRI biomarkers of aging and Alzheimer’s disease neurodegeneration
medRxiv 2026
Preprint · OA
Childhood trauma, accelerated biological aging and chronic pain across two population cohorts
bioRxiv (Cold Spring Harbor Laboratory) 2020
Preprint · CC-BY
Recalibrating the Epigenetic Clock: Implications for Assessing Biological Age in the Human Cortex
Neuropsychopharmacology Reports 2024
Open access · CC-BY
Biological aging analysis based on DNA methylation status for social anxiety disorder
Epigenomics 2026
Citation only
Epigenetic age acceleration is not strongly associated with cardiorespiratory fitness in heart failure: a pilot study.
Frontiers in Aging Neuroscience 2022
Open access · CC-BY